Thrivent Financial for Lutherans’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22,887
| Closed | -$566K | – | 2550 |
|
|
2024
Q3 | $566K | Hold |
22,887
| – | – | ﹤0.01% | 2195 |
|
|
2024
Q2 | $580K | Sell |
22,887
-5,453
| -19% | -$138K | ﹤0.01% | 2159 |
|
|
2024
Q1 | $720K | Hold |
28,340
| – | – | ﹤0.01% | 2073 |
|
|
2023
Q4 | $642K | Sell |
28,340
-1,385
| -5% | -$31.4K | ﹤0.01% | 2113 |
|
|
2023
Q3 | $554K | Sell |
29,725
-14,117
| -32% | -$263K | ﹤0.01% | 2084 |
|
|
2023
Q2 | $1.14M | Buy |
43,842
+15,853
| +57% | +$412K | ﹤0.01% | 1722 |
|
|
2023
Q1 | $804K | Sell |
27,989
-7,470
| -21% | -$215K | ﹤0.01% | 1911 |
|
|
2022
Q4 | $1.05M | Buy |
35,459
+6,857
| +24% | +$203K | ﹤0.01% | 1702 |
|
|
2022
Q3 | $681K | Buy |
28,602
+4,314
| +18% | +$103K | ﹤0.01% | 1914 |
|
|
2022
Q2 | $542K | Buy |
24,288
+12,535
| +107% | +$280K | ﹤0.01% | 2059 |
|
|
2022
Q1 | $295K | Buy |
11,753
+4
| +0% | +$100 | ﹤0.01% | 2347 |
|
|
2021
Q4 | $421K | Buy |
11,749
+91
| +0.8% | +$3.26K | ﹤0.01% | 2240 |
|
|
2021
Q3 | $496K | Sell |
11,658
-107
| -0.9% | -$4.55K | ﹤0.01% | 2191 |
|
|
2021
Q2 | $509K | Sell |
11,765
-7
| -0.1% | -$303 | ﹤0.01% | 2172 |
|
|
2021
Q1 | $480K | Sell |
11,772
-8
| -0.1% | -$326 | ﹤0.01% | 2235 |
|
|
2020
Q4 | $533K | Hold |
11,780
| – | – | ﹤0.01% | 2103 |
|
|
2020
Q3 | $417K | Sell |
11,780
-107
| -0.9% | -$3.79K | ﹤0.01% | 2052 |
|
|
2020
Q2 | $448K | Sell |
11,887
-72
| -0.6% | -$2.71K | ﹤0.01% | 1957 |
|
|
2020
Q1 | $346K | Buy |
11,959
+597
| +5% | +$17.3K | ﹤0.01% | 1909 |
|
|
2019
Q4 | $589K | Buy |
11,362
+411
| +4% | +$21.3K | ﹤0.01% | 1807 |
|
|
2019
Q3 | $601K | Sell |
10,951
-198
| -2% | -$10.9K | ﹤0.01% | 1726 |
|
|
2019
Q2 | $453K | Buy |
11,149
+300
| +3% | +$12.2K | ﹤0.01% | 1877 |
|
|
2019
Q1 | $328K | Buy |
10,849
+329
| +3% | +$9.95K | ﹤0.01% | 1975 |
|
|
2018
Q4 | $354K | Buy |
10,520
+231
| +2% | +$7.77K | ﹤0.01% | 1744 |
|
|
2018
Q3 | $434K | Buy |
10,289
+174
| +2% | +$7.34K | ﹤0.01% | 1751 |
|
|
2018
Q2 | $324K | Buy |
10,115
+657
| +7% | +$21K | ﹤0.01% | 1863 |
|
|
2018
Q1 | $470K | Buy |
9,458
+338
| +4% | +$16.8K | ﹤0.01% | 1670 |
|
|
2017
Q4 | $492K | Buy |
9,120
+180
| +2% | +$9.71K | ﹤0.01% | 1700 |
|
|
2017
Q3 | $519K | Buy |
8,940
+140
| +2% | +$8.13K | ﹤0.01% | 1549 |
|
|
2017
Q2 | $434K | Buy |
8,800
+560
| +7% | +$27.6K | ﹤0.01% | 1585 |
|
|
2017
Q1 | $358K | Buy |
8,240
+320
| +4% | +$13.9K | ﹤0.01% | 1688 |
|
|
2016
Q4 | $388K | Buy |
7,920
+390
| +5% | +$19.1K | ﹤0.01% | 1614 |
|
|
2016
Q3 | $360K | Buy |
7,530
+540
| +8% | +$25.8K | ﹤0.01% | 1633 |
|
|
2016
Q2 | $375K | Buy |
6,990
+470
| +7% | +$25.2K | ﹤0.01% | 1560 |
|
|
2016
Q1 | $292K | Buy |
6,520
+200
| +3% | +$8.96K | ﹤0.01% | 1627 |
|
|
2015
Q4 | $241K | Buy |
+6,320
| New | +$241K | ﹤0.01% | 1681 |
|
|
2015
Q2 | – | Sell |
-5,450
| Closed | -$224K | – | 1839 |
|
|
2015
Q1 | $224K | Buy |
5,450
+200
| +4% | +$8.22K | ﹤0.01% | 1542 |
|
|
2014
Q4 | $214K | Buy |
+5,250
| New | +$214K | ﹤0.01% | 1567 |
|